was probed by using an insulin-receptor-related peptide phosphorylated on tyrosine (peptide 1142-1153). Two major peaks of PTPase activity were resolved from the particulate (Triton X-100-soluble) fraction of human placenta by chromatography on DEAE-cellulose. The two peaks were purified 1300-2300-fold; other peaks of PTPase activity (> 15 %) were not detected. Properties of the PTPases indicated that they corresponded to subtypes IA and lB. Both subtypes appeared capable of catalysing dephosphorylation of all autophosphorylation sites in three domains of the insulin receptor, with no appreciable difference in the pattern of dephosphorylation detected by two-dimensional tryptic-peptide mapping. The tyrosine-1 150 domain of the insulin receptor in triply phosphorylated form was found to be highly sensitive to the action of both PTPases, and was dephosphorylated at least 4 times faster than the doubly and singly phosphorylated forms of the tyrosine-1 150 domain or phosphorylation sites in other domains by either PTPase. This is significant, as the level of the triphosphotyrosine-1150 species has been shown to correlate well with the capacity of the insulin-receptor tyrosine kinase to phosphorylate other proteins. Both subtypes also dephosphorylated autophosphorylated epidermal-growthfactor (EGF) receptor by > 95 %. Placental particulate (and cytosolic) PTPase activity against either receptor distributed 2: 1 between subtypes lA and B as assayed in the presence of EDTA. In summary, PTPases within two major subtypes have been identified as phosphotyrosyl-insulin and -EGF-receptor phosphatases in -vitro. The PTPases identified exhibit high affinities for substrates and high activities in cells, which is commensurate with the PTPases being important in vivo in controlling or reversing autophosphorylation-induced regulatory or signalling events.
INTRODUCTION
Insulin and epidermal-growth-factor (EGF) receptors are ligand-activated tyrosine-specific protein kinases (Ullrich & Schlessinger, 1990) . Both receptors are transmembranous, with ligand-binding sites located extracellularly and tyrosine kinase active sites in cytoplasmic domains. Whereas the EGF receptor is a single polypeptide unit, the insulin receptor is composed of two types of subunit, linked predominantly in a fl-a-a-fl configuration by disulphide bonds. The a-subunit forms the major part of the insulin-binding site, whereas the f8-subunit contains the tyrosine kinase active site. Mutagenesis of a critical lysine group involved in ATP binding in either receptor does not alter ligand-binding properties, but abrogates cellular responses to the ligand (Chen et al., 1987; Chou et al., 1987; Ebina et al., 1987; Honegger et al., 1987) . Therefore the tyrosine kinase activities of the receptors appear essential for signal transduction.
Insulin and EGF receptors both undergo ligand-stimulated autophosphorylation on tyrosine residues, perhaps by a mechanism involving transphosphorylation. Four autophosphorylation sites (tyrosines 1068, 1086, 1148 and 1173) in the EGF receptor near the C-terminus of the receptor appear to define a region autoinhibitory to tyrosine kinase activity that can be relieved by autophosphorylation [reviewed by Carpenter & Cohen (1990) and Ullrich & Schlessinger (1990) ]. There are at least seven sites of autophosphorylation in the insulin receptor: tyrosines 1316 and 1322 in the C-terminal domain; tyrosines 1146, 1150 and 1151 in the tyrosine-1 150 domain; and putatively tyrosines 953 and 960 or 972 in the juxtamembrane domain (Tornqvist et al., 1987 (Tornqvist et al., , 1988 White et al., 1988; King & Sale, 1990) . Autophosphorylation of the insulin receptor activates by up to 200-fold the ability of the tyrosine kinase to phosphorylate other substrates (Rosen et al., 1983; Yu & Czech, 1984) . Consequently dephosphorylation, and not merely dissociation of bound insulin, is necessary to terminate tyrosine kinase activity.
Analysis of the state of autophosphorylation of the f-subunit during phosphorylation and the ability of the insulin receptor to catalyse substrate phosphorylation show that activation of the tyrosine kinase correlates best with phosphorylation of all three tyrosine residues (1146, 1150 and 1151) in the tyrosine-1150 domain (White et al., 1988; Flores-Riveros et al., 1989) . The tyrosine-1150 domain in triply phosphorylated form is also, relative to other phosphorylated forms of the insulin receptor, highly sensitive to dephosphorylation by particulate and soluble protein-tyrosine-phosphatases (PTPases) present in rat liver extracts (King & Sale, 1990; Sale, 1991 (King et al., 1991; Sale, 1991 EXPERIMENTAL Materials DEAE-cellulose (DE52) and phosphocellulose paper were obtained from Whatman, Maidstone, Kent, U.K. Phosphocellulose (fine mesh), heparin-agarose and Brij 35 were from Sigma Chemical Co., Poole, Dorset, U.K. Other biochemicals and chemicals were obtained from sources described in King & Sale (1990) or Smith et al. (1988) .
Purification of PTPases
All procedures were carried out at 4 'C. Preparation of particulate and soluble fractions and DEAE-cellulose chromatography were modified from Tonks et al. (1988a) .
Preparation of particulate and soluble fractions from human placenta. Placentas were trimmed of amnion and chorion, cut into small pieces, washed in 10 mM-Tris/HCl, pH 7.4, containing 150 mM-NaCl, and homogenized for 3 x 15 s in a Waring Blender in 2 vol. of 10 mM-imidazole/HCl (pH 7.2)/0.25 M-sucrose/ 5 mM-EDTA / 0.1 % (v/v) ,-mercaptoethanol, containing 0.002% (w/v) phenylmethanesulphonyl fluoride, 1 mM-benzamidine and 1 ,ug of leupeptin/ml. The homogenate was centrifuged at 27000 g for 1 h. The supernatant was filtered through glass wool and was designated the cytosolic fraction. The pellet was homogenized for 30 s in a Waring Blender in 2 vol. of the above imidazole buffer containing 0.5% (v/v) Triton X-100, followed by stirring for I h and centrifugation at 27 000 g for 1 h. After filtration through glass wool, the supernatant was designated the particulate (Triton X-100-soluble) fraction.
Chromatography on DEAE-cellulose. The cytosolic or particulate (Triton X-100-soluble) fractions from one placenta were stirred overnight with 30 ml of DEAE-cellulose slurry [equilibrated in Buffer A: 10 mM-imidazole/HCl (pH 7.2), 2 mm-EDTA, 0.1 % fl-mercaptoethanol, 0.002 % phenylmethanesulphonyl fluoride and 1 mM-benzamidine] per g of protein. The slurry was then poured into a column (5 cm x -15 cm), washed with Buffer A and eluted (250 ml/h) with a 1-litre linear 0-0.3 MNaCl gradient in Buffer A. Pooled peaks of PTPase activity were dialysed overnight against Buffer A.
Chromatography on phosphocellulose. PTPases were passed three times through a phosphocellulose column (-1 ml bed volume/ml of dialysis residue) equilibrated in Buffer B [Buffer A containing 0.01 % (v/v) Brij 35]. The column was washed with 10 bed vol. of Buffer B and eluted (45 ml/h) with a linear 0-0.6 MNaCl gradient (5 times the bed volume) in Buffer B. Pooled peaks of PTPase activity were dialysed overnight against Buffer B.
Chromatography on heparin-agarose. PTPases were recycled three times through a heparin-agarose column (10 ml bed volume) equilibrated in Buffer B. The column was washed with 5 bed vol. of Buffer B and eluted (45 ml/h) with a linear 0-0.6 MNaCl gradient (50 ml) in Buffer B. After dialysis overnight against Buffer B, the pooled fractions were stored at -70 'C. Preparation of 32P-labelled substrates Insulin and EGF receptors were co-purified from human placental membranes solubilized in Triton X-100 by affinity chromatography on wheat-germ-agglutinin-agarose and autophosphorylated (>95 % of 32P recovered in phosphoamino acids was attached to tyrosine) as previously described (King et al., 1991) . RCM (reduced, carboxamidomethylated and maleylated) lysozyme was prepared and phosphorylated by using the lectin-purified preparation of insulin and EGF receptors as described by Tonks et al. (1988a) . Peptide 1142-1153, Thr-ArgAsp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys, corresponding to amino acids 1142-1153 in the human insulin pro-receptor was synthesized by a solid-phase method (Merrifield, 1986) . The peptide was phosphorylated by using the lectin-agarose-purified preparation of insulin and EGF receptors as previously described (King & Sale, 1988b) . 32P-peptide 1142-1153 was separated from non-peptide-bound 32P by chromatography on an AG1-X2 (acetate form) column (5 ml) with 6% (v/v) acetic acid, and freeze-dried. The stoichiometry of phosphorylation was approx. 0.1 mol/mol of peptide. Analysis by electrophoresis at pH 3.5 (pyridine/acetic acid/water, 1:10:89, by vol.) on cellulose thinlayer plates showed that under the phosphorylation conditions used the 32P-peptide was -90 % monophosphorylated. The 32P-peptide was dissolved in 50 mM-Hepes (pH 7.4)/0.2 mM-dithiothreitol for use in dephosphorylation assays.
Dephosphorylation assays 32P-labelied RCM lysozyme and 32P-peptide 1142-1153. Samples (20 u1) containing PTPase activity in 10 mM-imidazole/HCl (pH 7.2), 0.1 % fl-mercaptoethanol, 0.002 % phenylmethanesulphonyl fluoride, 0.01 % Brij 35 and 1 mM-benzamidine, and samples (30 1l) of 32P-labelled RCM lysozyme (11 #UM, based on 32p) or 32P-labelled peptide 1142-1153 (10,ul, 0.18 ,UM) were mixed together after preincubation at 30°C for 5 min. EDTA and poly(Glu,Tyr) (4: 1) were present as indicated.
After incubation for 20 min at 30 IC, 32P released from the substrates was measured as described by Tonks et al. (1988a) or King & Sale (1988b) .
Autophosphorylated receptors. 32P-labelled receptors (% 0.5 mg of protein/ml) were incubated with the indicated PTPase activity at 30°C in 50 mM-Hepes (pH 7.4)/10 mM-EDTA containing 0.1 % Triton X-100 and 2,ug of leupeptin/ml. Dephosphorylations were terminated by mixing 40,u1 portions with 10 l of SDS sample buffer, followed by SDS/PAGE and autoradiography (King & Sale, 1990) . In some experiments insulinreceptor fl-subunits were excised and subjected to twodimensional tryptic-peptide mapping on cellulose thin-layer plates (King & Sale, 1990) . Insulin-receptor amino acids are numbered in accordance with Ullrich et al. (1985) .
RESULTS
A major objective of this study was the identification of PTPases active against autophosphorylated insulin receptor. To facilitate this, an insulin-receptor-related peptide was employed as substrate, rather than an artificial substrate. Artificial substrates may not contain the phosphotyrosine in the correct sequence, which could lead to critical species of PTPase being overlooked. A synthetic peptide (residues 1142-1153) derived from the regulatory (tyrosine-1 150) autophosphorylation domain of the insulin receptor was chosen. Peptide 1142-1153, after phosphorylation on tyrosine, was a potent substrate for dephosphorylation by PTPases present in extracts of human placenta. PTPase activity was recovered in the particulate (Triton X-100-soluble) and cytosolic fractions of human placenta in the ratio -1.5: 1 with the 32P-peptide as substrate.
Chromatography of the particulate (Triton X-100-soluble) fraction obtained from human placenta on DEAE-cellulose yielded two peaks of PTPase activity as assayed with 32P-peptide 1142-1153, that were eluted at -55 mM-NaCl and -95 mmNaCl (Fig. 1) . With 32P-labelled phosphotyrosyl RCM lysozyme as substrate, two peaks of PTPase activity were again resolved from the particulate Triton X-100-soluble fraction on DEAEcellulose, eluted at -55 mm-and 95 mM-NaCl (Fig. 1) as found by Tonks et al. (1988a) . These peaks were designated IA (Jones et al., 1989) . The overall purification achieved in this study for the particulate IA and lB PTPase subtypes was -2300-and -1300-fold respectively. The yield of each subtype activity was -40% from the DEAEcellulose step.
To confirm the distinct identity of the two particulate PTPases purified in the present work, the effects of known modulators of PTPase activity were tested (Tonks et al., 1988b) . Subtype lB was found to be several-fold more sensitive to activation by EDTA and inhibition by poly(Glu,Tyr) (4: 1) than the IA subtype (Table 1 ). These observations, coupled with the elution position of the two species from DEAE-cellulose, confirm their identities (Tonks et al., 1988a,b the C-terminal, regulatory (tyrosine-1150) and putative juxtamembrane domains of the f-subunit, as analysed by twodimensional mapping of tryptic phosphopeptides. Although after 25 min incubation with the PTPases some of the singly phosphorylated forms of the tyrosine-1 150 and putative juxtamembrane domains remained, the amounts present in incubations with either PTPase were less than the amount of the domains initially phosphorylated, indicating that some dephosphorylation of the singly phosphorylated species had occurred. The relative resistance of these singly phosphorylated species to dephosphorylation supports observations made with PTPases present in rat liver particulate and soluble extracts (King & Sale, 1990) . The tyrosine-1150 domain of the insulin receptor in triply phosphorylated form was highly sensitive to dephosphorylation by either PTPase (Figs. 4 and 5) . Disappearance of this species was associated with increases in the doubly phosphorylated derivative and then the singly phosphorylated derivative as the diphospho-species disappeared. The doubly phosphorylated Cterminal and putative juxtamembrane domain species were dephosphorylated 4-7-fold more slowly than the triply phosphorylated tyrosine-l 150 domain species by either PTPase. The singly phosphorylated derivative of the C-terminal domain was only weakly detected during dephosphorylation with either PTPase subtype. Consequently the singly phosphorylated Cterminal domain species is rapidly dephosphorylated once formed. This is analogous to the phosphorylation of this domain (Tornqvist et 
DISCUSSION
In this study a synthetic insulin-receptor-related peptide (residues 1142-1153) was primarily used in the identification of PTPases active against autophosphorylated insulin receptor. This was important because use of alien substrates in earlier studies could have led to critical species of PTPase, with the highest specificity, being overlooked or underestimated.
With phosphotyrosyl-peptide 1142-1153 as substrate. PTPase activity was detected in both the particulate (Triton X-100-soluble) and cytosolic fractions of human placenta in the ratio of -1.5:1. This compares with a ratio (particulate: cytosolic) in rat liver of 4:1 with 32P-peptide 1142-1153 as substrate and 2-3:1 with autophosphorylated insulin or EGF receptors as substrate (King & Sale, 1988a,b) . However, the ratio in rat liver was measured for the whole particulate fraction, whereas the ratio in placenta applies to the Triton X-100-soluble component. Certain PTPases in the particulate fraction of human placenta that are believed to be associated with the cytoskeleton have been reported to be resistant to solubilization with Triton X-100 (Roome et al., 1988) . Because most PTPase activity against the autophosphorylated insulin receptor resided in the particulate fraction compared with the cytosolic fraction, greater emphasis has been given to characterizing particulate activities in the present study.
Two peaks of PTPase activity were purified from the particulate (Triton X-100 soluble) fraction of human placenta with 32P_
peptide 1142-1153 as substrate. On the basis of their properties, the species appear to correspond to the IA and lB subtypes characterized by Tonks et al. (1988b) . These PTPases are believed to contain different catalytic subunits. Significantly, use of the 32P-peptide 1142-1153 as substrate did not detect any other major species of PTPase activity during chromatography on DEAE-cellulose, phosphocellulose or heparin-agarose. Of fundamental importance is whether a single species of PTPase can dephosphorylate all sites of autophosphorylation in the insulin receptor, or whether the concerted action of more than one PTPase is required. Also of importance is whether the same or different PTPases act on autophosphorylated insulin and EGF receptors. Both particulate PTPase subtypes IA and lB appeared able to dephosphorylate all autophosphorylation sites in the C-terminal, tyrosine-1 150 and putative juxtamembrane domains of the insulin-receptor f-subunit. Both particulate subtypes IA and lB dephosphorylated autophosphorylated EGF receptor by > 95 %, and thus were not selective in the choice of receptor that could act as substrate. No appreciable differences in the pattern of dephosphorylation of the various autophosphorylation sites present in the insulin receptor by either the IA or lB particulate subtypes was detected (Figs. 4 and 5) .
Autophosphorylation of the tyrosine-1150 domain of the insulin-receptor ,-subunit appears important in controlling tyrosine kinase activity towards other substrates. Activation of substrate phosphorylation correlates well with production of the triphosphotyrosine-1 150 domain species during phosphorylation (White et al., 1988; Flores-Riveros et al., 1989) . The triphosphotyrosine-1 150 domain and activation of substrate phosphorylation are both exquisitely sensitive to the action of rat liver PTPases present in particulate and soluble extracts, with disappearance of the triphospho species correlating well with deactivation of the tyrosine kinase (King et al., 1991) . Therefore it was important to identify specific species of PTPase that exhibit higher activity against the triphosphotyrosine-1150
